Imaging advances in the diagnosis of neuroendocrine tumors;Avances en la localización de los tumores neuroendocrinos cou las técnicas de imagen

Anales de Medicina Interna

Volumn 21, Issue 10, 2004, Pages 491-494

  Vázquez Muñoz, Enrique ^a,b   Franco Lopez A ^a   Perez Villacastin B ^a   Pallardo Sanchez L F ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b NONE   (Spain)

Author keywords

Glucagonoma; Insulinoma; Neuroendocrine tumor

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ADULT; ANGIOGRAPHY; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; GLUCAGONOMA; HUMAN; INSULINOMA; METASTASIS; NEUROENDOCRINE TUMOR; SCINTISCANNING; TUMOR LOCALIZATION;

DIAGNOSTIC IMAGING; FEMALE; GLUCAGONOMA; HUMANS; INSULINOMA; MIDDLE AGED; NEUROENDOCRINE TUMORS;

EID: 8844224102     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Modlin IM, Tang LH. Approaches to the diagnosis of gut neuroendocrine tumors: The last word. Gastroenterology 1997; 112: 583-90.
2. Scott BA, Gatenby RA. Imaging advances in the diagnosois of endocrine neoplasia. Curr Opinion Oncol 1998; 10: 37-42.
3. Tomassetti P, Migliori M, Lalli S, Campana D, Tomasetti V, Corinaldesi R. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol 2001; 12: 595-99.
4. Chatziioannou A, Kehagias D, Mourikis D, Antoniou A, Limouris G, Kaponis A, et al. Imaging and localization of pancreatic insulinomas. J Clin Imaging 2001; 25: 275-83.
5. Huai JC, Zhang W, Niu HO, Su ZX, McNamara JJ, Machi J. Localization and surgical treatment of pancreatic tumors guided by intraoperative ultrasound. Am J Surg 1998; 175: 18-21.
6. Stacpoole PW. The glucagonoma syndrome. Clinical features, diagnosis and treatment. Endocr Rev 1981; 2: 347-48.
7. Kessinger A, Lemon HM, Foley JF. The glucagonoma syndrome and its management. J Surg Oncol 1977; 9: 419-24.
8. Kuzin N, Egorov A, Kondrashin S, Lotov A, Lotov AN, Kuzenestov NS et al. Preoperative and intraoperative topographic diagnosis of insulinomas. World J Surg 1998; 22: 593-98.
9. King CMP, Rezcek RH, Dacie JE, Was JAH. Imaging islet cell tumors. Clin Radiol 1994; 49: 295-03.
10. Fidler JL, Fletcher JG, Reading CC, Andrews JC, Thompson CB, Grant CS et al. Preoperative detection of pancreatic insulinomas on multiphasic helical CT. AJR 2003; 181: 775-80.
11. Smelka RC, Custodio CM, Balci NC, Woosley JT. Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. J Magn Reso imaging 2000; 148: 141-148.
12. Boden G. Glucagonomas and insulinomas. Gastroenterol Clin North Am 1989; 18: 831-35.
13. Smelka RC, Kelekis NL, Molina PL, Sharp TJ, Calvo P, Pancreatic masses with inconclusive findings of spiral CT: Is thear a role for MRI. J Magn Reson Imaging 1996; 6: 585-88.
14. Kelekis NL, Somelka RC, Molina PL, Doerr ME. ACTH-secreting islet cell tumors: appearance on dynamic gadolinium enhanced MRI. Magn Reson Iomaging 1995; 13: 641-44.
15. Nichols DM, Logle JRC, Zentler-Munro P. Pancreatic angiography in still valuable preoperatively in insulinoma. BMJ 1997; 314: 1552.
16. Glover JR, Shorvon PJ, Lees WR, Endoscopic ultrasound for localization of islet cell tumors. Gut 1992; 33: 108-10.
17. King CM, Rezker RH, Dacie JE, Was JAH. Imaging islet cell tumors. Clin Radiol 1994; 49: 295-03.
18. Andersen MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM. Endoscopic ultrasound highly accurate and directs management in patients with neuroendocrine tumors of pancreas. Am J Gastroenterol 2000; 95: 2271-77.
19. Mateos Fernández JM, Pons Pons F, Pelfort DF, Vidal-secart S, Lomeña Caballero F, Herranz garcía-Romero R. In111-pentetreotida en el estudio de tumores que expresan receptores para la somatostatina. Rev Esp Med Nuclear 1999; 18: 325-30.
20. Bauer W, Briner U. A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 1982; 31: 1133-40.
21. Krenning EP, Kwekkebonnm DJ, Backer VH, Breeman WAP, Kooij PPM, Oci HY. Somatostatin-receptors scintigraphy with (111In-DTPA-Phe) and (111-Tyr3)-octreotide: The Rotteerdan experience with more than 1.000 patients. Eur J Nucl Med 1993; 20: 716-31.
22. Krausz Y, Bar-Ziv J, Jong RBJ. Somatostatin receptor scintigraphy in the management of gastroenteropancreatic tumors. Am J Gastroenterol 1998; 93: 66-70.
23. Lipp RW, Schnedl WJ, Stauber R, Ranner G, Leb G, Krejs J. Scintigraphic long-term follow-up of a patient with metastatic glucagonoma. Am J Gastroenterol 3000; 95: 1818-20.
24. Jhonso DS, Coel MN, Bornemann M. Current imaging and possible therapeutic management of glucagonoma tumors: a case report. Clin Nucl Med 2000; 25: 120-25.
25. Cadiot G, lebathi R, Sarda L. Preoperative detection of duodenal gastrinoma and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Gastroenterology 1996; 11I: 845-54.
26. Gibril F, Reynolds JC, Doppman JL. Somatostatin receptor scintigraphy; its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. Ann Intern Med 1996; 125: 26-34.
27. Bertherat J, Tenenbaum F, Perlemoine K, Videau C, Alberini JL. Richard B et al. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study. J Clin Endocrinol Metab 2003; 88: 5353-60.
28. Modlin IM, Tang LH. Approaches to the diagnosis of gut neuroendocrine tumors: The last word (today). Gastoenterology 1977; 112: 583-90.
29. Oberg K. Interferon-alpha versus somatostatin or te combination of both in gastro-enteropancreatic tumours. Digestion 1996; 57: 81-83.
30. Nakamoto Yuji, Higashi T, Sakahara H, Tamaki N, Itoh K, Imamura M, Konishi J. Evaluation of pancreatic islet cel tumors by fluorine-18 fluorodeoxyglucose positron emission tomography. Clin Nucl Med 2000; 25: 115-20.